Literature DB >> 33244188

Technology of deep brain stimulation: current status and future directions.

Joachim K Krauss1, Nir Lipsman2, Tipu Aziz3, Alexandre Boutet4, Peter Brown5, Jin Woo Chang6, Benjamin Davidson2, Warren M Grill7, Marwan I Hariz8, Andreas Horn9, Michael Schulder10, Antonios Mammis11, Peter A Tass12, Jens Volkmann1,13, Andres M Lozano14.   

Abstract

Deep brain stimulation (DBS) is a neurosurgical procedure that allows targeted circuit-based neuromodulation. DBS is a standard of care in Parkinson disease, essential tremor and dystonia, and is also under active investigation for other conditions linked to pathological circuitry, including major depressive disorder and Alzheimer disease. Modern DBS systems, borrowed from the cardiac field, consist of an intracranial electrode, an extension wire and a pulse generator, and have evolved slowly over the past two decades. Advances in engineering and imaging along with an improved understanding of brain disorders are poised to reshape how DBS is viewed and delivered to patients. Breakthroughs in electrode and battery designs, stimulation paradigms, closed-loop and on-demand stimulation, and sensing technologies are expected to enhance the efficacy and tolerability of DBS. In this Review, we provide a comprehensive overview of the technical development of DBS, from its origins to its future. Understanding the evolution of DBS technology helps put the currently available systems in perspective and allows us to predict the next major technological advances and hurdles in the field.

Entities:  

Mesh:

Year:  2020        PMID: 33244188      PMCID: PMC7116699          DOI: 10.1038/s41582-020-00426-z

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  151 in total

1.  A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: the Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR).

Authors:  Atchar Sudhyadhom; Ihtsham U Haq; Kelly D Foote; Michael S Okun; Frank J Bova
Journal:  Neuroimage       Date:  2009-04-10       Impact factor: 6.556

2.  The Effects of Closed-Loop Medical Devices on the Autonomy and Accountability of Persons and Systems.

Authors:  Philipp Kellmeyer; Thomas Cochrane; Oliver Müller; Christine Mitchell; Tonio Ball; Joseph J Fins; Nikola Biller-Andorno
Journal:  Camb Q Healthc Ethics       Date:  2016-10       Impact factor: 1.284

Review 3.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

4.  Responsive cortical stimulation for the treatment of medically intractable partial epilepsy.

Authors:  Martha J Morrell
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

5.  Deep brain stimulation for Parkinson's disease: defining the optimal location within the subthalamic nucleus.

Authors:  Maarten Bot; P Richard Schuurman; Vincent J J Odekerken; Rens Verhagen; Fiorella Maria Contarino; Rob M A De Bie; Pepijn van den Munckhof
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-20       Impact factor: 10.154

6.  An improved genetic algorithm for designing optimal temporal patterns of neural stimulation.

Authors:  Isaac R Cassar; Nathan D Titus; Warren M Grill
Journal:  J Neural Eng       Date:  2017-12       Impact factor: 5.379

7.  The rationale driving the evolution of deep brain stimulation to constant-current devices.

Authors:  Jeff M Bronstein; Michele Tagliati; Cameron McIntyre; Robert Chen; Tyler Cheung; Eric L Hargreaves; Zvi Israel; Michael Moffitt; Erwin B Montgomery; Paul Stypulkowski; Jay Shils; Timothy Denison; Jerrold Vitek; Jens Volkman; Jeffrey Wertheimer; Michael S Okun
Journal:  Neuromodulation       Date:  2014-08-29

8.  Modified pulse shapes for effective neural stimulation.

Authors:  Lorenz Hofmann; Martin Ebert; Peter Alexander Tass; Christian Hauptmann
Journal:  Front Neuroeng       Date:  2011-09-28

9.  Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting.

Authors:  Simon Little; Elina Tripoliti; Martijn Beudel; Alek Pogosyan; Hayriye Cagnan; Damian Herz; Sven Bestmann; Tipu Aziz; Binith Cheeran; Ludvic Zrinzo; Marwan Hariz; Jonathan Hyam; Patricia Limousin; Tom Foltynie; Peter Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-08-16       Impact factor: 10.154

10.  Stimulating at the right time: phase-specific deep brain stimulation.

Authors:  Hayriye Cagnan; David Pedrosa; Simon Little; Alek Pogosyan; Binith Cheeran; Tipu Aziz; Alexander Green; James Fitzgerald; Thomas Foltynie; Patricia Limousin; Ludvic Zrinzo; Marwan Hariz; Karl J Friston; Timothy Denison; Peter Brown
Journal:  Brain       Date:  2016-12-22       Impact factor: 13.501

View more
  40 in total

1.  Safety and Efficacy of Cell Transplantation on Improving Motor Symptoms in Patients With Parkinson's Disease: A Meta-Analysis.

Authors:  Jiaming Wang; Yu Tian; Xin Shi; Zhaohai Feng; Lei Jiang; Yujun Hao
Journal:  Front Hum Neurosci       Date:  2022-05-06       Impact factor: 3.169

2.  Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.

Authors:  Wen-Li Dong; Jia-Hong Zhong; Yun-Qing Chen; Jin-Feng Xie; Yun-Yun Qin; Jiang-Ping Xu; Ning-Bo Cai; Meng-Fan Li; Lu Liu; Hai-Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2021-09-16       Impact factor: 6.150

Review 3.  Advances in DBS Technology and Novel Applications: Focus on Movement Disorders.

Authors:  Sina R Potel; Sara Marceglia; Sara Meoni; Suneil K Kalia; Rubens G Cury; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2022-07-15       Impact factor: 6.030

4.  Basic Tips: How Do I Start Programming Deep Brain Stimulation in Parkinson Disease Patients?

Authors:  Carolina Gorodetsky; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2021-04-06

Review 5.  The Expanding Horizon of Neural Stimulation for Hyperkinetic Movement Disorders.

Authors:  Anna Latorre; Lorenzo Rocchi; Anna Sadnicka
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

Review 6.  Directions of Deep Brain Stimulation for Epilepsy and Parkinson's Disease.

Authors:  Ying-Chang Wu; Ying-Siou Liao; Wen-Hsiu Yeh; Sheng-Fu Liang; Fu-Zen Shaw
Journal:  Front Neurosci       Date:  2021-06-14       Impact factor: 4.677

Review 7.  Closed-Loop Neural Prostheses With On-Chip Intelligence: A Review and a Low-Latency Machine Learning Model for Brain State Detection.

Authors:  Bingzhao Zhu; Uisub Shin; Mahsa Shoaran
Journal:  IEEE Trans Biomed Circuits Syst       Date:  2021-12-09       Impact factor: 3.833

Review 8.  Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe.

Authors:  Marenka Smit; Alberto Albanese; Monika Benson; Mark J Edwards; Holm Graessner; Michael Hutchinson; Robert Jech; Joachim K Krauss; Francesca Morgante; Belen Pérez Dueñas; Richard B Reilly; Michele Tinazzi; Maria Fiorella Contarino; Marina A J Tijssen
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003

Review 9.  The Medial Septum as a Potential Target for Treating Brain Disorders Associated With Oscillopathies.

Authors:  Yuichi Takeuchi; Anett J Nagy; Lívia Barcsai; Qun Li; Masahiro Ohsawa; Kenji Mizuseki; Antal Berényi
Journal:  Front Neural Circuits       Date:  2021-07-08       Impact factor: 3.492

10.  Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease.

Authors:  Pusheng Quan; Kai Wang; Shi Yan; Shirong Wen; Chengqun Wei; Xinyu Zhang; Jingwei Cao; Lifen Yao
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.